Literature DB >> 28314510

t-Butyl pyridine and phenyl C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists.

Sunho Lee1, Dong Wook Kang2, HyungChul Ryu3, Changhoon Kim1, Jihyae Ann1, Hobin Lee1, Eunhye Kim4, Sunhye Hong4, Sun Choi4, Peter M Blumberg5, Robert Frank-Foltyn6, Gregor Bahrenberg6, Hannelore Stockhausen6, Thomas Christoph6, Jeewoo Lee7.   

Abstract

A series of 2-substituted 6-t-butylpyridine and 4-t-butylphenyl C-region analogues of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides were investigated for hTRPV1 antagonism. The analysis of structure activity relationships indicated that the pyridine derivatives generally exhibited a little better antagonism than did the corresponding phenyl surrogates for most of the series. Among the compounds, compound 7 showed excellent antagonism toward capsaicin activation with Ki=0.1nM and compound 60S demonstrated a strong antiallodynic effect with 83% MPE at 10mg/kg in the neuropathic pain model. The docking study of 7S in our hTRPV1 homology model indicated that the interactions between the A/B-regions of 7S with Tyr511 and the interactions between the t-butyl and ethyl groups in the C-region of 7S with the two hydrophobic binding pockets of hTRPV1 contributed to the high potency.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Analgesic; TRPV1 antagonists; Vanilloid receptor 1

Mesh:

Substances:

Year:  2017        PMID: 28314510      PMCID: PMC6959544          DOI: 10.1016/j.bmc.2017.03.004

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  29 in total

1.  Structure activity relationships of benzyl C-region analogs of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides as potent TRPV1 antagonists.

Authors:  Jihyae Ann; Aeran Jung; Mi-Yeon Kim; Hyuk-Min Kim; HyungChul Ryu; Sunjoo Kim; Dong Wook Kang; Sunhye Hong; Minghua Cui; Sun Choi; Peter M Blumberg; Robert Frank-Foltyn; Gregor Bahrenberg; Hannelore Stockhausen; Thomas Christoph; Jeewoo Lee
Journal:  Bioorg Med Chem       Date:  2015-10-09       Impact factor: 3.641

2.  Analgesic potential of TRPV1 antagonists.

Authors:  Philip R Kym; Michael E Kort; Charles W Hutchins
Journal:  Biochem Pharmacol       Date:  2009-03-05       Impact factor: 5.858

Review 3.  Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks.

Authors:  Gilbert Y Wong; Narender R Gavva
Journal:  Brain Res Rev       Date:  2008-12-25

Review 4.  Modulation of the TRPV1 channel: current clinical trials and recent patents with focus on neurological conditions.

Authors:  Luciano De Petrocellis; Aniello S Moriello
Journal:  Recent Pat CNS Drug Discov       Date:  2013-12

5.  α-Substituted 2-(3-fluoro-4-methylsulfonamidophenyl)acetamides as potent TRPV1 antagonists.

Authors:  Phuong-Thao Tran; Ho Shin Kim; Jihyae Ann; Sung-Eun Kim; Changhoon Kim; Mannkyu Hong; Van-Hai Hoang; Van T H Ngo; Sunhye Hong; Minghua Cui; Sun Choi; Peter M Blumberg; Robert Frank-Foltyn; Gregor Bahrenberg; Hannelore Stockhausen; Thomas Christoph; Jeewoo Lee
Journal:  Bioorg Med Chem Lett       Date:  2015-04-12       Impact factor: 2.823

6.  The cloned capsaicin receptor integrates multiple pain-producing stimuli.

Authors:  M Tominaga; M J Caterina; A B Malmberg; T A Rosen; H Gilbert; K Skinner; B E Raumann; A I Basbaum; D Julius
Journal:  Neuron       Date:  1998-09       Impact factor: 17.173

7.  Novel hepatitis C virus replicon inhibitors: synthesis and structure-activity relationships of fused pyrimidine derivatives.

Authors:  A Chris Krueger; Darold L Madigan; David W Beno; David A Betebenner; Robert Carrick; Brian E Green; Wenping He; Dachun Liu; Clarence J Maring; Keith F McDaniel; Hongmei Mo; Akhteruzzaman Molla; Christopher E Motter; Tami J Pilot-Matias; Michael D Tufano; Dale J Kempf
Journal:  Bioorg Med Chem Lett       Date:  2012-02-02       Impact factor: 2.823

Review 8.  Multisteric TRPV1 nocisensor: a target for analgesics.

Authors:  János Szolcsányi; Zoltán Sándor
Journal:  Trends Pharmacol Sci       Date:  2012-10-12       Impact factor: 14.819

9.  2-(3-Fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists: structure activity relationships of the 2-oxy pyridine C-region.

Authors:  Shivaji A Thorat; Dong Wook Kang; HyungChul Ryu; Myeong Seop Kim; Ho Shin Kim; Jihyae Ann; Taehwan Ha; Sung-Eun Kim; Karam Son; Sun Choi; Peter M Blumberg; Robert Frank; Gregor Bahrenberg; Klaus Schiene; Thomas Christoph; Jeewoo Lee
Journal:  Eur J Med Chem       Date:  2013-04-11       Impact factor: 6.514

Review 10.  Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway.

Authors:  Martin J Gunthorpe; Boris A Chizh
Journal:  Drug Discov Today       Date:  2008-12-26       Impact factor: 7.851

View more
  1 in total

1.  Pyrazole C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists.

Authors:  Sunho Lee; Changhoon Kim; Jihyae Ann; Shivaji A Thorat; Eunhye Kim; Jongmi Park; Sun Choi; Peter M Blumberg; Robert Frank-Foltyn; Gregor Bahrenberg; Hannelore Stockhausen; Thomas Christoph; Jeewoo Lee
Journal:  Bioorg Med Chem Lett       Date:  2017-08-12       Impact factor: 2.823

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.